Back to Search Start Over

Bleomycin and scuba diving: where is the harm?

Authors :
Stan B. Kaye
Ronald de Wit
Gerrit Stoter
Stefan Sleijfer
Alan Horwich
Dirk Sleijfer
Ben Mead
Medical Oncology
Source :
Lancet Oncology, 8(11), 954-955. Lancet Publishing Group, Lancet Oncology, 8(11), 954-955. ELSEVIER SCIENCE INC
Publication Year :
2007
Publisher :
Lancet Publishing Group, 2007.

Abstract

Testicular cancer is the most frequent malignant disease in men aged 15–40 years. Due to its sensitivity to chemotherapeutic drugs, most patients, including those with widespread metastatic disease, can now be cured. Bleomycin is an essential component of the most effective chemotherapy regimen for testicular cancer—ie, bleomycin, etoposide, and cisplatin [BEP].1 However, bleomycin is feared for its induction of bleomycin-induced pneumonitis (BIP), which is sometimes fatal.2 After reports in the 1980s of perioperative complications that were ascribed to bleomycin, high inspired-oxygen fractions during anaesthesia were avoided, as were high inspired-oxygen fractions under hyperbaric circumstances, such as scuba diving.

Details

ISSN :
14745488 and 14702045
Volume :
8
Issue :
11
Database :
OpenAIRE
Journal :
The Lancet Oncology
Accession number :
edsair.doi.dedup.....191d1fefcdf8cf5cfc27405d6506b209